Enhancement of subchondral bone quality by alendronate administration for the reduction of cartilage degeneration in the early phase of experimental osteoarthritis

Clinical and Experimental Medicine

Volumn 11, Issue 4, 2011, Pages 235-243

  Zhang, Liu ^a   Hu, Hongyu ^a   Tian, Faming ^a   Song, Huiping ^a   Zhang, Yingze ^b  

^a NORTH CHINA COAL MEDICAL COLLEGE   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Alendronate; Anterior cruciate ligament transaction; Cartilage; Osteoarthritis; Subchondral bone

Indexed keywords

ALENDRONIC ACID; BONE MORPHOGENETIC PROTEIN 2; COLLAGENASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; BONE DENSITY; BONE MASS; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL RABBIT; FEMUR; FEMUR CONDYLE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NONHUMAN; OSTEOARTHRITIS; OSTEOLYSIS; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TRABECULAR BONE; X RAY ABSORPTION SPECTROSCOPY;

ABSORPTIOMETRY, PHOTON; ALENDRONATE; ANIMALS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEIN 2; CARTILAGE; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; HISTOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 13; MICROSCOPY; OSTEOARTHRITIS; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 84862908345     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0131-z     Document Type: Article

References (37)

1. Hayami T, Pickarski M, Zhuo Y, Wesolowski GA, Rodan GA, le Duong T (2006) Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 38(2):234-243 (Pubitemid 43165790)
2. Behets C, Williams JM, Chappard D, Devogelaer JP, Manicourt DH (2004) Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. J Bone Miner Res 19(11): 1821-1826 (Pubitemid 41103433)
3. Karsdal MA, Byrjalsen I, Henriksen K, Riis BJ, Lau EM, Arnold M, Christiansen C (2010) The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: A 14-day randomized study. Osteoarthritis Cartilage 18(2):150-159
4. Goldring MB, Goldring SR (2010) Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 1192:230-237
5. Muehleman C, Green J, Williams JM, Kuettner KE, Thonar EJ, Sumner DR (2002) The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage. Osteoarthritis Cartilage 10(3):226-233 (Pubitemid 34189573)
6. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J et al (2004) The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50(4): 1193-1206 (Pubitemid 38480830)
7. Dong QR, Chen XY (2007) Experimental study on biomechanical changes of subchondral bone in osteoarthritis. China J Trauma 23(5):386-389
8. Carbone LD, Nevitt MC, Wildy K, Barrow KD, Harris F, Felson D et al (2004) The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 50(11):3516-3525 (Pubitemid 39488676)
9. Ding M, Danielsen CC, Hvid I (2008) The effects of bone remodeling inhibition by alendronate on three-dimensionalmicroarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. Calcif Tissue Int 82(1):77-86
10. Corrado A, Santoro N, Cantatore FP (2007) Extra-skeletal effects of bisphosphonates. Joint Bone Spine 74(1):32-38 (Pubitemid 46240986)
11. Watts NB, Diab DL (2010) Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 95(4):1555-1565
12. Corrado A, Cantatore FP (2005) The bisphosponates: Chemical characteristics, skeletal biological effects and extra-skeletal effects. Reumatismo 57(3):142-153 (Pubitemid 41441650)
13. Stresing V, Daubiné F, Benzaid I, Mönkkönen H, Clézardin P (2007) Bisphosphonates in cancer therapy. Cancer Lett 257(1): 16-35 (Pubitemid 47464698)
14. Asikoǧlu M, Ozguney I, Ozcan I, Orumlu O, Guneri T, Koseoǧlu K et al (2008) The absorption of (99 m) Tc-alendronate given by rectal route in rabbits. Pharm Dev Technol 13(3):213-220 (Pubitemid 351882239)
15. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659-661 (Pubitemid 351348146)
16. Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research (2002) Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. U.S. Food and Drug Administration Rockville, Maryland, USA
17. Armstrong S, Read R, Ghosh P (1994) The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol 21(4):680-688 (Pubitemid 24126765)
18. Wang SX, Laverty S, Dumitriu M, Plaas A, Grynpas MD (2007) The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Arthritis Rheum 56(5):1537-1548 (Pubitemid 46764083)
19. Sniekers YH, Intema F, Lafeber FP, van Osch GJ, van Leeuwen JP, Weinans H et al (2008) A role for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models. BMC Musculoskelet Disord 9:20
20. Goldring MB, Goldring SR (2007) Osteoarthritis. J Cell Physiol 213(3):626-634 (Pubitemid 350058254)
21. Bobinac D, Spanjol J, Zoricic S, Maric I (2003) Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans. Bone 32(3):284-290 (Pubitemid 36349532)
22. Patel V, Issever AS, Burghardt A, Laib A, Ries M, Majumdar S (2003) MicroCT evaluation of normal and osteoarthritic bone structure in human knee specimens. J Orthop Res 21(1):6-13 (Pubitemid 36157615)
23. Kirvick DL, Pijamowski GJ, Schaeffer DJ (1994) Three-dimensional kinematics of the intact and cranial cruciate ligamentdeficient stifle of dogs. J Biomech 27(1):77-87 (Pubitemid 24012909)
24. Lorenz H, Richter W (2006) Osteoarthritis: Cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem 40(3):135-163 (Pubitemid 43833326)
25. Konttinen YT, Salo T, Hanemaaijer R, Valleala H, Sorsa T, Sutinen M et al (1999) Collagenase-3 MMP-13/and its activators in rheumatoid arthritis: Localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol 18(4): 401-412 (Pubitemid 29397452)
26. Fernandes JC, Martel-Pelletier J, Lascau-Coman V, Moldovan F, Jovanovic D, Raynauld JP et al (1998) Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: An immunohistochemical study. J Rheumatol 25(8):1585-1594 (Pubitemid 28364767)
27. Yoon BS, Lyons KM (2004) Multiple functions of BMPs in chondrogenesis. J Cell Biochem 93(1):93-103
28. Fischer L, Boland G, Tuan RS (2002) Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 277(34): 30870-30878 (Pubitemid 34970787)
29. Gomes RR Jr, Joshi SS, Farach-Carson MC, Carson DD (2006) Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts. Differentiation 74(1): 53-63
30. Izzo MW, Pucci B, Tuan RS, Hall DJ (2002) Gene expression profiling following BMP-2 induction of mesenchymal chondrogenesis in vitro. Osteoarthritis Cartilage 10(1):23-33 (Pubitemid 34120987)
31. Nakase T, Miyaji T, Tomita T, Kaneko M, Kuriyama K, Myoui A et al (2003) Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthritis Cartilage 11(4):278-284 (Pubitemid 36410880)
32. Wan Mei, Cao Xu (2005) BMP signaling in skeletal development. Biochem Biophys Res Commun 328(3):651-657 (Pubitemid 40208302)
33. Muraoka T, Hagino H, Okano T, Enokida M, Teshima R (2007) Role of subchondral bone in osteoarthritis development: A comparative study of two strains of guinea pigs with and without spontaneously occurring osteoarthritis. Arthritis Rheum 56(10):3366-3374 (Pubitemid 47585431)
34. Van Beek ER, Löwik CW, Papapoulos SE (2002) Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: The role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors. Bone 30(1):64-70 (Pubitemid 34044302)
35. Hofstaetter JG, Wang J, Yan J, Glimcher MJ (2009) The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits. Osteoarthritis Cartilage 17(3):362-370
36. Jones MD, Tran CW, Li G, Maksymowych WP, Zernicke RF, Doschak MR (2010) In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat. Arthritis Rheum 62(9):2726-2735
37. Neogi T, Nevitt MC, Ensrud KE, Bauer D, Felson DT (2008) The effect of alendronate on progression of spinal osteophytes and disc-space narrowing. Ann Rheum Dis 67(10):1427-1430